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The Microprocessor complex (DGCR8/Drosha) is
required for microRNA (miRNA) biogenesis but also
binds and regulates the stability of several types of
cellular RNAs. Of particular interest, DGCR8 controls
the stability of mature small nucleolar RNA (snoRNA)
transcripts independently of Drosha, suggesting
the existence of alternative DGCR8 complex(es)
with other nucleases to process a variety of cellular
RNAs. Here, we found that DGCR8 copurifies with
subunits of the nuclear exosome, preferentially asso-
ciating with its hRRP6-containing nucleolar form.
Importantly, we demonstrate that DGCR8 is essen-
tial for the recruitment of the exosome to snoRNAs
and to human telomerase RNA. In addition, we
show that the DGCR8/exosome complex controls
the stability of the human telomerase RNA compo-
nent (hTR/TERC). Altogether, these data suggest
that DGCR8 acts as an adaptor to recruit the exo-
some complex to structured RNAs and induce their
degradation.
INTRODUCTION
MicroRNAs are small noncoding RNAs that negatively regulate
gene expression, influencing many biological processes (Ebert
and Sharp, 2012). The nuclear step of miRNA biogenesis is cata-
lyzed by the Microprocessor complex, comprising the RNase III
enzyme Drosha and the double-stranded RNA-binding protein
DGCR8 (DiGeorge critical region 8) and results in the production
of precursor miRNAs (pre-miRNAs) (Denli et al., 2004; Gregory
et al., 2004; Han et al., 2004). DGCR8 recognizes the RNA
substrate in the nucleus through two double-stranded RNAbind-
ing motifs and acts as an anchor to direct the endonucleolytic
cleavage by Drosha 11 base pairs-away from the base of theMolecpri-miRNA hairpin (Nguyen et al., 2015). This processing event
generates stem loop precursors (pre-miRNAs), which are ex-
ported to the cytoplasm by Exportin 5 and are further processed
by Dicer into mature miRNAs (reviewed by Ha and Kim, 2014;
Krol et al., 2010). The initial biochemical purification of Drosha
revealed the existence of two different molecular weight com-
plexes. A smaller complex, which is the minimally active catalyt-
ical complex, is composed of DGCR8 and Drosha and a larger
complex containing several RNA-associated proteins including
a subset of hnRNP proteins, DEAD box, and DEAH box family
of RNA helicases and double-stranded RNA-binding proteins
(Gregory et al., 2004; Siomi and Siomi, 2010).
Initially, noncanonical functions for the Microprocessor were
suggested by the finding that a stem loop in the 50UTR of
the DGCR8mRNA is bound and cleaved by the Microprocessor,
in a negative feedback loop (Han et al., 2009; Kadener et al.,
2009; Triboulet et al., 2009). A DGCR8 HITS-CLIP experiment re-
vealed that, in addition to pri-miRNAs, the Microprocessor binds
to a large number of structured RNAs that harbor a predicted
secondary structure resembling that of a pri-miRNA. These
include several hundred mRNAs, long intergenic noncoding
RNAs (lincRNAs), small nucleolar RNAs (snoRNAs), and trans-
posable elements, including LINE-1 elements (Heras et al.,
2013; Macias et al., 2012). We previously found that the stability
of snoRNAs is controlled in a DGCR8-dependent but Drosha-
independent manner, suggesting the existence of an alternative
DGCR8 complex, whereby its association with a yet-unidentified
nuclease(s) could regulate the stability of this subset of RNAs
(Macias et al., 2012).
Themajor RNA decaymachinery in eukaryotes is the exosome
complex that plays an important role in the processing and
degradation of RNAs, both in the nucleus and in the cytoplasm
and is functionally regulated by accessory factors (Mitchell
et al., 1997; reviewed by Chlebowski et al., 2013; Houseley
et al., 2006; Lorentzen et al., 2008). In yeast, this complex medi-
ates the processing and controls steady-state levels of rRNA,
snoRNAs, antisense RNAs, and cryptic unstable transcripts
(Lykke-Andersen et al., 2011; Sloan et al., 2012). By contrast,
the functions of this complex in higher eukaryotes are less wellular Cell 60, 873–885, December 17, 2015 ª2015 The Authors 873
characterized. In humans, the nuclear form of the inactive core
exosome is composed by nine different subunits, which form a
ring structure and associate to two different catalytical subunits
hDIS3 and hRRP6 (also called PM/SCl-100) (Houseley and Toll-
ervey, 2008; Liu et al., 2006; Lykke-Andersen et al., 2011).
Human DIS3 localizes in the nucleoplasm and acts as an endo/
exonuclease, whereas the exonuclease hRRP6 concentrates
mainly in the nucleolus (Lebreton et al., 2008; Tomecki et al.,
2010). Additional associated factors have been proposed to
confer substrate specificity to this machinery. The TRAMP com-
plex, initially discovered in yeast, targets noncoding and aber-
rant RNAs by addition of a short noncanonical poly(A) tail, which
in turn directs these transcripts for exosomal degradation
(LaCava et al., 2005; Vana´cova´ et al., 2005; Wyers et al., 2005).
In humans, the trimeric Nuclear Exosome Targeting (NEXT)
complex acts to recruit the exosome to promoter-upstream
transcripts (PROMPTs) and to actively transcribed RNA-
polymerase II transcripts (Lubas et al., 2011). It also promotes
a functional link of the exosome with the cap bind complex
(CBC) that is essential for transcription termination (Andersen
et al., 2013). Here, we set out to identify the DGCR8 complex
that is responsible for the Drosha-independent degradation of
mature snoRNAs. We used mass spectrometry analysis of
DGCR8 immunoprecipitations and found that DGCR8 interacts
with components of the nuclear exosome, in particular the cata-
lytically active hRRP6 subunit in the nucleolus. Importantly, we
confirmed that DGCR8 is essential for the recruitment of the exo-
some to a particular subset of nucleolar transcripts, such as
snoRNAs. Interestingly, we also show that the DGCR8/exosome
complex, but not the canonical Microprocessor, controls the
stability of another small transcript, the human telomerase
RNA component (hTR/TERC). Altogether, these data suggest
the existence of an alternative DGCR8 complex, whereby
DGCR8 acts as an adaptor to recruit the exosome to double-
stranded structured RNAs and promote their degradation.
RESULTS
DGCR8 Interacts with the Human RNA Exosome
Complex
In order to identify DGCR8-interacting proteins, we performed
immunoprecipitation (IP) coupled to mass spectrometry (MS)
analysis of two different tagged versions of DGCR8 (FLAG and
T7) in parallel with Drosha (FLAG) and their respective controls.
Whole lanes from the immunoprecipitations were sent for MS
analysis and a representative gel of the purification is shown
on Figure S1A (available online). In order to define exclusive
DGCR8-interacting partners, we selected those proteins that in-
teracted with both tagged versions of DGCR8 and subtracted
those that also interacted with Drosha (see Supplemental Exper-
imental Procedures). This resulted in a total of 49 proteins that
were exclusive to DGCR8 purification (Figures 1A and S1B; for
a complete list, see Table S1). Gene ontology analyses revealed
a significant enrichment for nucleolar-associated proteins and
RNA processing factors, including proteins involved in RNA
degradation andwith exonuclease activity (Figure 1B). Strikingly,
this analysis revealed that five out of the nine core subunits of the
RNA exosome as well as the catalytical component hRRP6, a874 Molecular Cell 60, 873–885, December 17, 2015 ª2015 The Auth30-50 exoribonuclease, interact with DGCR8 (see Figure S1B
and Table S1). These results were validated with immunoprecip-
itations of the three overexpressed proteins (T7-DGCR8, FLAG-
DGCR8, and FLAG-Drosha) in the presence or absence of
RNases, followed by western blot analysis with specific anti-
bodies. We confirmed the interaction of DGCR8 with hRRP6
and with subunits of the core exosome complex, hRRP40,
and hRRP41 in an RNA-independent manner (Figure 1C). By
contrast, the interactions with Fibrillarin, a component of
the C/D snoRNP particle, and dyskerin, an H/ACA snoRNP fac-
tor ,were severely reduced in the presence of RNase, suggesting
RNA-dependent interactions (Figure 1C, compare lanes 2 and 4
with lanes 7 and 9). Importantly, the other catalytical subunit that
can associate with the nuclear exosome, hDIS3, could not be
immunoprecipitated with DGCR8, confirming our MS analyses
and suggesting that DGCR8 interacts with the nucleolar
form of the exosome complex that is associated to hRRP6.
Remarkably, none of these proteins were immunoprecipitated
by Drosha, except its canonical Microprocessor partner,
DGCR8, confirming that these are bona fide DGCR8 interacting
partners. Immunoprecipitations of endogenous DGCR8 in the
presence of RNase confirmed its interaction with endogenous
hRRP6 (Figure 1D, lane 4). In agreement, we also pulled down
DGCR8 when endogenous hRRP6 was immunoprecipitated in
an RNA-independent manner (Figure 1E, lane 4). Altogether,
these data suggest that DGCR8 associates with the RNA exo-
some complex, and mostly with the nucleolar form that contains
the hRRP6 exonuclease. Importantly, Drosha did not interact
with this complex, demonstrating that DGCR8 can form different
complexes with other nucleases.
DGCR8 Forms Two Different Molecular Weight
Complexes
The DGCR8 interactome analysis described above strongly sug-
gests that DGCR8may be part of at least two cellular complexes,
one with Drosha to form the Microprocessor complex, and an
additional complex with the exosome. In order to elucidate this
possibility, we examined the sedimentation patterns of the native
complexes formed by overexpressed DGCR8 and Drosha in
5%–30% glycerol gradients. For this purpose, immunoprecipi-
tated FLAG-DGCR8 and FLAG-Drosha complexes were eluted
under native conditions and loaded on the gradients. After
centrifugation, the gradients were divided in twenty-two frac-
tions and analyzed by western blot with specific antibodies.
FLAG-Drosha immunoprecipitates were mainly present in frac-
tions 6–15 (Figure 2A, top panel), whereas FLAG-DGCR8 sedi-
mentation extended to heavier-molecular-weight fractions
(fractions 16–22) (Figure 2A, bottom panel). We followed this
observation by pooling light and heavy fractions and running
them in two separate lanes. We confirmed that FLAG-Drosha
coimmunoprecipitated DGCR8 in the light fractions (Figure S2A,
lanes 8–10), but not hRRP6 (Figure 2B, upper panel). By contrast,
FLAG-DGCR8 complexes were present in both light and heavy
fractions together with hRRP6 (Figure 2B, lower panel), suggest-
ing that hRRP6 can also form a high-molecular-weight complex
with DGCR8, where Drosha ismostly absent. In addition, we also
examined the sedimentation patterns of endogenous DGCR8,
Drosha, and selected protein components of the exosomeors
Figure 1. DGCR8 Interacts with the Exosome
(A) Representation of the number of interacting partners identified by mass spectrometry (MS) analysis of immunoprecipitated T7-DGCR8, FLAG-DGCR8 and
FLAG-Drosha using BioVenn (for a complete list of proteins identified by MS analyses, see Table S1; for DGCR8-exclusive interacting partners, see Figure S1B).
(B) Gene ontology analyses of the 49 DGCR8-exclusive interacting partners (vertical dashed line represents significance, p% 0.05).
(C) Validation of proteins interacting with T7-DGCR8, FLAG-DGCR8, and FLAG-Drosha by immunoprecipitation followed by western blot analysis with specific an-
tibodies, in the presence (lanes 6–10) or absence of RNase A (lanes 1–5). The RT-PCRamplification of Gapdh serves as a control for RNase treatment (bottompanel).
(D and E) Reciprocal analysis of coimmunoprecipitated DGCR8 and hRRP6 endogenous proteins by western blot analysis with specific antibodies, in the
presence (lanes 2 and 4) or absence of RNase A (lanes 1 and 3).from HEK293T nuclear extracts in 5%–30% glycerol gradients.
We observed that Drosha sedimented at the top of the gradient
overlapping with DGCR8 (Figure 2C, fractions 7–11), whereas
the exosome core component hRRP41 as well as hRRP6, the
catalytic subunit of the exosome, cosedimented at fractions
12–17 (Figure 2C). Interestingly, DGCR8, but not Drosha, was
also present in the heavier fractions, recapitulating the behavior
of overexpressed DGCR8 (compare Figures 2C and 2A). In sum,
these data are consistent with DGCR8 being part of at least two
cellular complexes, a lighter molecular complex in association
with Drosha, but also an association with hRRP6/exosome to
form a heavier-molecular-weight complex.
DGCR8 Interacts with hRRP6 in the Nucleolus
In order to dissect the region in DGCR8 that is required for the
interaction with hRRP6, we analyzed the interaction of seven
V5-tagged deletion mutants of DGCR8 and also an additional
mutation that abrogates the ability of DGCR8 to bind RNA (T7-
DGCR8 dRBD1&2 mut) in transfected HEK293T cells (Figures
3A and 3D). Only full-length DGCR8 (v5-D8) and the D8 1–692Molecfragment, lacking the C-terminal region, could efficiently be coim-
munoprecipitated with hRRP6 (Figure 3B, lanes 2 and 5). In addi-
tion, binding of hRRP6 to DGCR8 was barely detected with
DGCR8 mutants that lacked the N-terminal region, where the
NLS (nuclear localization signal) is located (D8 276–773, 484–
736, 484–750, 484–773), as expected (Figure 3B, lanes 6–9). We
also observed that the presence of the dsRNA binding motifs
was required to efficiently coimmunoprecipitate endogenous
hRRP6 (D8 1–483 and D8 1–614) (Figure 3B, lanes 3 and 4). This
was confirmed by further evaluating a T7-DGCR8 construct that
contained specific mutations in the dsRNA binding motifs (T7-
DGCR8 dRBD1&2 mut), which are known to abolish RNA binding
(AA-KK in dRBD1 and AS-KK in dRBD2, as described in Yeom
et al., 2006). These point mutations abolished the interaction of
DGCR8notonlywithhRRP6,butalsowithothercorecomponents
of the exosome, such as hRRP40 and hRRP41, but did not
compromise interaction with Drosha (Figure 3C, lanes 2 and 3).
These results show that whereas Drosha interacts with DGCR8
through the C-terminal region (Yeom et al., 2006; Figure S3),
the interaction with the exosome requires an intact DGCR8ular Cell 60, 873–885, December 17, 2015 ª2015 The Authors 875
Figure 2. DGCR8 and the Exosome Coexist in a Complex
(A) Sedimentation patterns of immunopurified FLAG-Drosha and FLAG-DGCR8 native complexes in 5%–30%glycerol gradient fractions, as revealed by western
blot analysis with an anti-FLAG antibody. ‘‘Light’’ denotes lighter-molecular-weight fractions, whereas ‘‘heavy’’ indicates heavier molecular fractions. The
migration of the molecular weight markers is indicated at the top (to see uncropped versions of these images, see Figure S2B).
(B) Western blot of coimmunoprecipitated hRRP6 with FLAG-Drosha (top panel) and FLAG-DGCR8 (bottom panel) after glycerol gradient fractionation. Fractions
from a 5%–30%glycerol gradient were pooled into light (lane 2), corresponding to fractions 1–11, and heavy (lane 3), corresponding to fractions 12–22, and run in
a single lane for sensitivity purposes.
(C) Sedimentation patterns of endogenous Drosha, DGCR8, hRRP6, and hRRP41 proteins in 5%–30% glycerol gradients from nuclear HEK293T cell extracts, as
revealed by western blot analysis with specific antibodies. Lysates run in all gradients were produced in the presence of DNase and RNase.RNA-binding domain (Figure 3D). Next,we askedwhether the two
alternative DGCR8 complexes displayed a differential subcellular
localization. We analyzed the endogenous intracellular distribu-
tion of hRRP6, DGCR8 and Drosha by western blot analysis
following nucleoplasmic/nucleolar fractionation of HeLa cells.
LaminB and eIF4AIII were used as nucleoplasmic markers,
whereas Fibrillarin was used as a nucleolar maker (Figure 3E).
Weobserved that hRRP6wasmainly present in thenucleolar frac-
tion andDroshawasmainly nucleoplasmic, whereas DGCR8was
more abundant in the nucleoplasmic fraction but also present in
the nucleolus (Figure 3E), suggesting that the interaction of
DGCR8 and hRRP6 is restricted to the nucleolar compartment.
This was confirmed by immunoprecipitation of transiently ex-
pressed FLAG-DGCR8 from the nucleoplasmic and nucleolar
fractions, which revealed the preferential interaction of endoge-
nous hRRP6 with DGCR8 in the nucleolar fraction (Figure 3F,
lane 2). Immunofluorescence experiments revealed that wild-
type T7-DGCR8 was present both in the nucleoplasm and nucle-
olus, as revealed by costaining with the nucleolarmarker, nucleo-
lin (Figure 3G, top panel), whereas a T7-DGCR8 dRBD1&2 mut,
which does not interact with hRRP6, was mostly absent from
the nucleolar compartment and preferentially localized to nucleo-
plasm (Figure 3G, bottom panel). Interestingly, the only DGCR8
mutant that was also able to efficiently coimmunoprecipitate
endogenous hRRP6 (D8 1–692) also localizes to the nucleolus
(Figure 3D). Furthermore, a bioinformatics prediction program876 Molecular Cell 60, 873–885, December 17, 2015 ª2015 The Auth(Scott et al., 2011) revealed a putative nucleolar localization signal
overlapping with the second dsRBD motif in DGCR8, which is in
agreement with the loss of nucleolar localization of a DGCR8 pro-
tein harboring a mutation in its dsRBD motifs (Figure 3G). Alto-
gether this suggests that the mutually exclusive presence of two
DGCR8complexes is basedondifferential subcellular localization
of the DGCR8 partners, Drosha and hRRP6, which are present
within the nucleoplasm and nucleolus, respectively.
DGCR8 Acts as an Adaptor for hRRP6 Recruitment to
snoRNAs
C/D box and H/ACA box snoRNAs associate to distinct sets of
snoRNP proteins and guide two different modifications to the
target RNAs, 20-O-methylation and pseudouridylation, respec-
tively (Tollervey and Kiss, 1997). They are mostly intronic and
transcribed as part of the host gene, and following splicing of
their host intron, their biogenesis involves trimming of the host in-
trons from the 50 and 30 end. Subsequent release of the mature
form of the snoRNA form is protected from further degradation
by the core snoRNP components (Kiss, 2006). The identification
of the exosome as a DGCR8 interacting partner in the nucleolus
led us to ask whether DGCR8 could be acting as an adaptor for
the recruitment of the exosome to snoRNAs. First, we tested
binding of endogenous DGCR8 and hRRP6 to mature and
precursor snoRNAs (host pre-mRNA) by immunoprecipitation
followed by qRT-PCR analysis (IP-qRT-PCR) (Figure 4A). Weors
Figure 3. DGCR8 and hRRP6 Interact in the Nucleolus
(A) Cartoon depicting the functional domains of DGCR8 (NLS, nuclear localization signal; Rhed, RNA-binding heme domain; WW, WW domain; dRBD1 and
dRBD2, double-stranded RNA binding domain 1 and 2 and Drosha-interacting region).
(B) Coimmunoprecipitation of V5-taggedwild-typeDGCR8 (V5-D8, lane 2), empty plasmid as a negative control (V5, lane 1), and the indicated DGCR8 truncations
(numbers represent amino acid positions, lanes 3–9). HEK293T cells transfected with these plasmids were subjected to immunoprecipitation of endogenous
hRRP6 (bottom panel) followed by western blot with anti-V5 antibody (top panel). Inputs are shown in the middle panel.
(C) HEK293T cells were transfected with plasmids overexpressing T7-tagged wild-type DGCR8 (T7-DGCR8) and a DGCR8 mutant with substitutions of critical
residues that abrogate binding to dsRNA (AA-KK in dRBD1, and AS-KK in dRBD2 (as depicted in A) and subjected to anti-T7 immunoprecipitation followed by
analyses of coimmunoprecipitated endogenous hRRP6, hRRP41, hRRP40, and Drosha proteins by western blot analysis.
(legend continued on next page)
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observed that both DGCR8 and hRRP6 did indeed associate to a
similar extent with two representative C/D and H/ACA mature
snoRNA molecules (mU16 and mU92, respectively) (Figures 4A
and S4A). DGCR8, but not hRRP6, associated to some extent
to their host pre-mRNAs (preU16 and preU92) (Figure 4A), and
as expected, we also detected binding of DGCR8, but not of
hRRP6, to a canonical Microprocessor substrate (pri-miR-24)
(Figure 4A). We confirmed that overexpressed DGCR8 associ-
ates to mature snoRNAs by IP-qRT-PCR, and that this binding
is specific, since this association was abolished when using a
mutant of DGCR8 that cannot longer bind dsRNA (T7-DGCR8
dRBD1&2 mut) (Figure 4B). In order to recapitulate these obser-
vations in vitro, we performed gel-shift assays with purified
FLAG-tagged versions of DGCR8, Drosha, hRRP6 and a catalyt-
ically dead mutant of hRRP6 (D313N, (Januszyk et al., 2011))
expressed in HEK293T cells (see representative purification in
Figure S4B). We observed that purified DGCR8 can directly
bind to mature U16, although this binding was less efficient
than to a canonical pri-miRNA (Figures 4C and S4C, lanes 1–4
compare molar ratios at the top of the panels); however, no bind-
ing was observed when using U1 snRNA as a negative control
(Figure S4D). As expected, we only observed binding of Drosha
to a canonical substrate, pri-miR-30c-1 (data not shown), but not
to U16 (Figures 4C, lanes 5–9). The addition of FLAG-hRRP6, or a
catalytically dead version of hRRP6, did not result in a shift (Fig-
ure 4C, lanes 13–18), and accordingly the combined addition of
DGCR8 and hRRP6 did not obviously change the migration of
the complex when compared to DGCR8 alone (Figure 4C, lanes
9–12). Taken together, these results suggest that DGCR8 could
be the factor that enables hRRP6 binding to snoRNAs, acting as
an adaptor protein to efficiently recruit the exosome complex to
these species. In order to test this possibility, we immunoprecip-
itated endogenous RRP6 protein from wild-type mouse embry-
onic stem cells (Dgcr8+/+), or cells lacking DGCR8 (Dgcr8/)
and analyzed RRP6 binding to mature snoRNAs by qRT-PCR
and northern blot (Figures 4D and 4E, respectively). Importantly,
we observed that mouse RRP6 binding to mature snoRNAs U16
andU92was abrogated in the absence of DGCR8 (Figure 4D and
Figure 4E, compare lanes 3 and 5). A similar result was obtained
by immunoprecipitating overexpressed Flag-hRRP6 in Dgcr8+/+
and Dgcr8/ cells (Figures S4E and S4F). This shows that
DGCR8 is essential to promote binding of hRRP6 to snoRNAs
and suggests that DGCR8 acts as an adaptor to recruit the exo-
some complex to mature snoRNAs.
DGCR8 and hRRP6 Control the Levels of Mature
snoRNAs
The in vivo data presented above showed that DGCR8 is neces-
sary to recruit hRRP6 to mature snoRNAs (Figure 4). Since both
factors are in the same complex, their codepletion should not(D) Table summarizing interactions of mutant and truncated DGCR8 with hRRP6
subcellular localizations, as previously characterized by Yeom et al., (2006).
(E) Western blot analysis of the subcellular distribution of Drosha, DGCR8, and hR
and eIF4AIII served as nucleoplasmic markers, whereas Fibrillarin is a nucleolar
(F) Western blot analysis of coimmunoprecipitated hRRP6 with FLAG-DGCR8 fro
(G) Subcellular localization of transiently expressed T7-DGCR8 and T7-DGCR8
whereas DAPI staining revealed nuclei.
878 Molecular Cell 60, 873–885, December 17, 2015 ª2015 The Authhave additional effects on snoRNA levels. In order to investigate
this, we quantified mature and precursor U16 snoRNAs by qRT-
PCR upon transient depletion of these factors (see precursor
U16 representation in Figure 5A). In agreement, depletion of
human DGCR8 and hRRP6 in HeLa and SH-SY5Y cells resulted
in a similar level of upregulation of mature U16 snoRNA, either
when depleted alone or in combination, as shown (Figures 5B
and S5B, respectively) or northern blot analyses (Figure S5A)
(for depletion levels, see Figures S5D and S5E). Importantly,
knockdown of other exosome-associated exonuclease factor
hDIS3, a putative component of the human TRAMP complex,
ZCCHC7, and a component of the NEXT complex, RBM7 (Lubas
et al., 2011), which did not copurify with DGCR8, led to slight
decrease of mature snoRNA levels, suggesting that these fac-
tors are not involved in the turnover of the mature form of this
snoRNA, but rather processing (Figure 5B). In addition, we
observed that the levels of the precursor host pre-mRNA, where
U16 is contained, remained constant upon transient depletion of
DGCR8 and hRRP6 (Figure 5C) that is in agreement with the fact
that hRRP6 did not bind this transcript (Figure 4). By contrast, the
transient depletion of hDIS3, RBM7, ZCCHC7 and a core
component of the exosome, hRRP41, led to an accumulation
of the U16 precursor (Figure 5C). This result, together with the
observed decrease in the mature form of the snoRNAs (Figures
5B and S5A), suggests that both the exosome and these adaptor
complexes are predominantly involved in the processing and
maturation of precursor snoRNAs. Finally, we also observed up-
regulation of mature snoRNA levels, but not of the precursor
forms, in mouse ESCs lacking DGCR8, confirming the effects
observed in human cells (Macias et al., 2012) (Figure S5C). Alto-
gether, these data strongly suggest that DGCR8 and hRRP6
form a cellular complex that controls mature snoRNA stability
in vertebrates.
SnoRNAs Are the Main Substrate of the DGCR8/hRRP6
Complex
In order to globally identify the substrates of the DGCR8/hRRP6
complex, we analyzed the overlap of the in vivo targets of the
hRRP6 nuclease identified by iCLIP in HEK293Ts (manuscript
in preparation) with the previously published HITS-CLIP targets
of DGCR8 (Macias et al., 2012). Only significant clusters that
overlapped from each CLIP experiment were considered as
potential true common RNA substrates for the DGCR8/hRRP6
complex (see Supplemental Experimental Procedures). This re-
sulted in the identification of 390 ncRNAs that were common
to DGCR8 and hRRP6, with snoRNAs being the most overrepre-
sented within this group (40% of the total common substrates,
with 156 snoRNAs bound from the 422 of the expressed
snoRNAswithin HEK293T cells), followed by tRNAs (23%of total
common substrates, represented by 93 different tRNAs)(shown in B and C), Drosha (shown in C and in Figure S3), and their respective
RP6 in nucleoplasmic (Np, lane 1) and nucleolar fractions (No, lane 2). Lamin B
marker.
m nucleoplasmic (lane 1) and nucleolar fractions (lane 2).
dRBD1&2 mut in HeLa cells. Nucleolin staining served as a nucleolar marker,
ors
Figure 4. DGCR8 Promotes hRRP6 Binding to Mature snoRNAs
(A) Schematic representation of primer pairs used to amplify mature snoRNAs (black box) or host pre-mRNAs (line represents the host intron) by qRT-PCR.
Analysis of the associated mature snoRNAs (mU16 and mU92) and host pre-mRNAs (preU16 and preU92) to immunoprecipitated endogenous DGCR8 and
hRRP6 in HEK293T cells. Pri-miR-24 serves as a positive control for a DGCR8 bound RNA and 7SK as a negative control. Values represented show at least the
average of two different biological replicates ± SD. The enrichment of each RNA species is expressed relative to the levels of amplification in the control IgG
immunoprecipitation (set to 1, represented as horizontal dashed line) and normalized to the levels in the Input material.
(B) Analysis of the associated mature snoRNAs (mU16 and mU92, left and right panels, respectively) to overexpressed wild-type T7-DGCR8 and T7-DGCR8
dRBD1&2 mutant by qRT-PCR, using the same analysis as in (A).
(legend continued on next page)
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Figure 5. Depletion of DGCR8 and hRRP6
Specifically Stabilizes Mature snoRNAs
(A) Schematic representation of U16 snoRNA
location in intron 3 of the host RPL4 pre-mRNA.
BS, branch site; E4, exon 4.
(B) HeLa cells were transiently depleted of DGCR8,
hRRP6, hDIS3, RBM7, and ZCCHC7, and the
levels of mature U16 were quantitated by qRT-
PCR, using primers depicted on top of the panel.
(C) Quantification of the host pre-mRNAs con-
taining U16 snoRNA in HeLa cells depleted for all
factors depicted in (B), but also including hRRP41.
For levels of depletion in (B) and (C), see Figure
S5D. All values represented in the two panels are
the average of at least three biological replicas
showing ± SEM. Asterisks denote significant p
value (%0.05) by Student’s t test.(Figure 6A). To assess the coverage of binding, we first identified
which snoRNAs are expressed in HEK293T cells, using a previ-
ously published small RNA-seq data set (Kishore et al., 2013).
From this set, we determined that both DGCR8 and hRRP6
bind to 117 out of 255 expressed C/D box snoRNAs (SNORD);
30 out of 145 expressed H/ACA box snoRNAs (SNORA), and
9 out of 22 expressed small Cajal RNAs (scaRNAs) (Figure 6A).
Next, we calculated the average read density of CLIP tags
from both hRRP6 and DGCR8 over snoRNA genes on a
genome-wide context. We found that DGCR8 and hRRP6 CLIP
reads fell mainly within the mature sequence of the snoRNAs
and that this was common between all the snoRNA classes
(Figure 6B).
So far, we have shown that the DGCR8/exosome complex is
involved in the turnover of the mature form of U16 snoRNA
(Figures 5B and S5A). Next, analysis of global snoRNA levels in
RNA-seq data from cells depleted of DGCR8 or hRRP6 showed
at least 19 commonly upregulated snoRNAs (Figure S6A), that
were also confirmed by northern blot analyses (Figure S6B).
Furthermore, we analyzed mature snoRNA levels in the absence
of RRP6 using RNA-seq data from mouse ESCs that lack RRP6
(EXOSC10) gene expression (Pefanis et al., 2015). Interestingly,
we observed that 64 of the mature snoRNAs expressed in this
cell line, were at least 2-fold upregulated in the absence of
RRP6 (Figure S6C). Altogether, these data reveal that both
DGCR8 and hRRP6 can bind a wide range of mature snoRNAs,
suggesting that the DGCR8/hRRP6 complex can regulate the
abundance of mature snoRNAs on a global scale.
DGCR8/hRRP6 Complex Controls hTR Stability and
Telomere Length
CLIP data also revealed that both DGCR8 and hRRP6 bind to
human telomerase RNA (hTR), with DGCR8 binding beingmostly(C) EMSA analysis of mature U16 snoRNA in the presence of increasing amounts
(D313N, catalytically dead mutant) (for purifications, see Figure S4B). The molar
(13 corresponds to 2.5 nM of protein and 2.5 nM of radiolabeled RNA).
(D and E) Analysis of mouse RRP6 association to snoRNAs in mouse embryonic s
PCR (D) and northern analyses (E). Quantitative RT-PCR data represent the averag
following the same procedure as in (A). Western blots for RRP6 immunoprecipita
880 Molecular Cell 60, 873–885, December 17, 2015 ª2015 The Authconcentrated toward the 30 end, where the H/ACA domain is
located (Figure 7A). We validated the binding of endogenous
DGCR8 and hRRP6 to hTR by Immunoprecipitation followed
by northern blot analysis of telomerase RNA (Figure 7B). Next,
we asked if DGCR8 was also acting as an adaptor to efficiently
recruit the exosome to this particular RNA. For this purpose,
we compared the amount of associated TERC RNA with RRP6
in the presence (Dgcr8+/+) or absence (Dgcr8/) of DGCR8.
Similarly to other snoRNAs (Figure 4), the presence of DGCR8
was required to observe efficient coimmunoprecipitation of
TERC RNA with RRP6 (Figure 7C, compare lanes 3 and 5).
Importantly, depletion of DGCR8, hRRP6 or a combination of
both resulted in hTR upregulation in HeLa cells as well as in
SH-SY5Y cells (Figures 7D and S7A, respectively), whereas no
changes in hTR levels were observed upon Drosha depletion
(Figure 7D; for depletion levels, see Figure S7B). We also found
that TERC levels remained constant in the absence of Dicer in
ESCs (Figure 7E), in agreement with previous reports (Benetti
et al., 2008); however, the absence of DGCR8 resulted in
increased TERC levels (Figure 7E). These results suggest that
the hTR transcript is a substrate of the DGCR8/hRRP6 complex
and that in the absence of these components, hTR abundance is
increased. Previous reports have suggested that increased
expression of the hTR RNA is sufficient to boost telomerase
activity in cultured cells (Cristofari and Lingner, 2006). Therefore,
we hypothesized that the lack of DGCR8 should be enough to
increase telomerase function, and this should result in an
abnormal elongation of the telomeres. To test this, we measured
the relative telomere length frommouse cells deficient in DGCR8
and Dicer using a qPCR based assay (Callicott and Womack,
2006). Notably, we observed a large increase in the telomeric
qPCR signal in the absence of DGCR8, when compared to the
parental cell line, but also in the absence of Dicer, whichof purified FLAG-DGCR8, FLAG-Drosha, FLAG-hRRP6 and FLAG-hRRP6 CAT
excess of protein versus radiolabeled RNA is indicated at the top of the panel
tem cells in the presence (Dgcr8+/+) or absence (Dgcr8/) of DGCR8 by qRT-
e of at least two different biological replicates ± SD (D). The data were analyzed
tion levels and copurified DGCR8 are shown in (E) (bottom panels).
ors
Figure 6. Genome-wide Identification of hRRP6 and DGCR8
Common RNA Substrates
(A) Distribution of DGCR8 and hRRP6 overlapping significant clusters across
ncRNAs loci. The colored column shows the distribution of snoRNA families
bound by both DGCR8 and hRRP6.
(B) Average read density of endogenous and overexpressed DGCR8 (left
panels) and FLAG-hRRP6 CLIP experiments (right panels) over snoRNA genes
and 50/30 flanking regions ± 50 nt.
Molecconfirmed previous reports (Figure 7F) (Benetti et al., 2008).
Alternatively, we used a dot blot assay to quantify the number
of telomeric repeats (TTAGGG) of the same genomic samples,
obtaining similar results (Figure S7C). All these data suggests
that the DGCR8 alternative complex may have a role in control-
ling the number of telomeric repeats by regulating hTR levels.
DISCUSSION
Recent reports have suggested extended noncanonical func-
tions for DGCR8 by describing its binding to a large number of
cellular RNAs, which may adopt multiple RNA secondary struc-
tures (Macias et al., 2012, 2013; Roth et al., 2013). Remarkably,
DGCR8 was shown to bind to a similar extent to precursor
miRNAs and mature snoRNA molecules (29% versus 28% of
the total DGCR8 binding sites in noncoding RNAs, respectively)
and also to control the stability of C/D and H/ACA box snoRNAs
in a Drosha-independent manner (Macias et al., 2012). Most
human snoRNAs are located within introns, and their biogenesis
is linked with the splicing of the host pre-mRNA (Hirose and
Steitz, 2001; Hirose et al., 2003); thereafter a complex intranu-
clear trafficking directs most snoRNAs to the nucleolus and/or
Cajal bodies (Kiss et al., 2006; Samarsky et al., 1998). Here,
we describe a cellular complex that comprises DGCR8 and
components of the nucleolar exosome that acts to control
mature snoRNA and human telomerase RNA levels. The overlap-
ping binding of DGCR8 and hRRP6 to both C/D and H/ACA box
snoRNAs as well as to human telomerase RNA (hTR), demon-
strated by independent CLIP experiments for these proteins,
suggests a general role for the DGCR8/exosome complex
in the regulation of snoRNA levels in the cell. In support of
this, preliminary results show that the DGCR8/hRRP6 complex
can regulate the abundance of mature snoRNAs on a global
scale, as shown by the presence of 19 commonly upregulated
snoRNAs (Figures 5B, S6A, and S6B). In the future, RNA-seq
experiments with specially designed snoRNA libraries in cells
depleted of DGCR8 or hRRP6 will help to determine the entire
repertoire of cellular RNAs regulated by this complex.
The exosome core exclusively associates with hRRP6 in
the nucleolus, whereas in the nucleoplasm is also associated
to hDIS3 (Blu¨thner and Bautz, 1992; Tomecki et al., 2010).
DGCR8 is present in the nucleoplasm but is also detectable in
the nucleolar compartment, where it interacts with many nucle-
olar factors (Figure 3 and also see Shiohama et al., 2007). By
contrast, Drosha is predominantly nucleoplasmic, whereas
hRRP6 is highly enriched in the nucleolus (Allmang et al.,
1999a; Blu¨thner and Bautz, 1992; Ge et al., 1992; Tomecki
et al., 2010). Here, we show that DGCR8 can only interact with
the exonuclease hRRP6 and the core exosome, when it is
located within the nucleolus. We envision a scenario where the
canonical DGCR8-containing Microprocessor complex pro-
cesses pri-miRNAs in the nucleoplasm, whereas the alternative
DGCR8-exosome complex targets and induces the degradation
of mature snoRNAs following their transport to the nucleolus.
Recent characterization of Rrp6 targets in yeast showed
enrichment for small, structured RNAs, such as tRNAs, snRNAs
and snoRNAs. Of particular interest was the binding of yeast
Rrp6 to the mature snoRNA snR40, which is suggestive of aular Cell 60, 873–885, December 17, 2015 ª2015 The Authors 881
Figure 7. DGCR8/hRRP6 Complex Controls
Human Telomerase RNA Levels
(A) Distribution of DGCR8 and hRRP6 CLIP reads
over hTR loci; numbers on the left represent
number of reads obtained from each library map-
ping to hTR.
(B and C) Northern analyses of associated
hTR RNA with immunoprecipitated endogenous
DGCR8 (lane 3) and hRRP6 (lane 4) in HEK293T
cells (B) and with mouse RRP6 in the presence
(Dgcr8+/+, lane 3) and absence (Dgcr8/, lane 5)
of DGCR8 in mESC (C).
(D) HeLa cells were transiently depleted of
DGCR8, hRRP6 and Drosha and hTR levels were
quantified by qRT-PCR (for depletion levels, see
Figures S5D and S7B).
(E) Levels of mouse TERC RNA were quantified by
qRT-PCR in the absence of DGCR8 (Dgcr8/)
and Dicer (Dicer/). All values represented in
panels (D) and (E) are the average of at least three
biological replicates ± SEM. Asterisks denote si-
ginificant p value (%0.05) by Student’s t test.
(F) Relative telomere length quantification by
qPCR of genomic DNA from cells lacking DGCR8
(Dgcr8/) and Dicer (Dicer/) and their respec-
tive wild-type controls (Dgcr8+/+ and Dicer+/+).
Numbers in brackets represent the passage
number. Absolute telomere quantification was
normalized to a single-copy gene (c-myc), as
described (Callicott and Womack, 2006). Values
represent the average of three biological
replicates ± SD.role for this component in the surveillance and degradation of
mature snoRNAs (Schneider et al., 2012). However, yeast Rrp6
has been also shown to be involved in the final trimming of pre-
cursor snoRNAs (Allmang et al., 1999b; van Hoof et al., 2000),
suggesting a role for Rrp6 both in snoRNA biogenesis, as well
as in decay. By contrast, the role of hRRP6 in snoRNA biogen-
esis and decay has not been characterized in humans, where it
is only known to be important for the maturation of 5.8S and
18S rRNA, as well as for the decay of histone mRNAs and
PROMPTs (Mullen and Marzluff, 2008; Schilders et al., 2007;
Sloan et al., 2013). This is most likely to be an hRRP6-dependent
but DGCR8-independent function, since mouse Dgcr8/ ESCs
do not display any significant defect in rRNA biogenesis (Wang
et al., 2007) or histone mRNA levels (data not shown). Our results
suggest that, at least for the snoRNAs studied here, hRRP6 is
not involved in snoRNA biogenesis, as it was described in yeast,
rather it acts in concert with DGCR8 to specifically control
mature snoRNA levels but not their precursors. This difference
could also be explained by the absence of a DGCR8 homolog
in yeast and the larger repertoire of ancillary proteins available
to deal with the complexity of RNAs in higher order eukaryotes.
Only recently, it was shown that human DIS3 is the main
snoRNA-processing enzyme, whereas it was also suggested
that RRP6 rather controls the levels of mature snoRNAs, as
shown by northern blot analysis of a few selected snoRNAs
(Szczepin et al., 2015).
Human telomerase is a ribonucleoprotein particle, containing
the telomerase enzyme (TERT), which acts as a reverse tran-
scriptase while the RNA component hTR/TERC serves as a882 Molecular Cell 60, 873–885, December 17, 2015 ª2015 The Authtemplate for the enzyme (Egan and Collins, 2012; Miracco
et al., 2014). Analysis of the CLIP experiments for both DGCR8
(Macias et al., 2012) and hRRP6 (Figure 6) identified human
telomerase RNA (hTR) as a putative substrate for this complex.
The vertebrate telomerase RNA, TERC, contains a 30 H/ACA
snoRNA-like domain that binds H/ACA snoRNP proteins, which
are essential to maintain correct levels of this RNA. Indeed, mu-
tations impairing the function of these proteins lead to reduced
hTR levels, which in turn results in poor telomere maintenance
(Mitchell et al., 1999a; Vulliamy et al., 2008; Walne et al., 2007).
Interestingly, this domain is only present in vertebrate organisms
(Chen et al., 2000) and is important for localization (Ja´dy et al.,
2004) and maturation of the hTR (Mitchell et al., 1999b; Theimer
et al., 2007). Human telomerase RNA is mainly localized in Cajal
bodies, although a minor proportion can also be found in the
nucleoli (Mitchell et al., 1999b). We observed that in the absence
of DGCR8, mouse ESCs displayed an increase in TERC levels
that were concomitant with an upregulation in the relative length
of telomeres.
In summary, we have described here an alternative DGCR8
complex in association with the nucleolar form of the exosome.
These data are compatible with a role for DGCR8 as an adaptor
that acts to recruit and target the exosome for the degradation
of mature snoRNAs and human telomerase RNA. This function
may be especially relevant in vivo, where the exosome needs
to be directed to different subclasses of RNA substrates by spe-
cific adaptor complexes in different subcellular compartments.
Further research will be aimed to identify and characterize all
the cellular targets of the DGCR8 alternative complex.ors
EXPERIMENTAL PROCEDURES
Cell Lines, Transfections, and Antibodies
HEK293T, HeLa, and SH-SY5Y cells were grown under standard conditions
in Dulbecco’s modified Eagle’s medium (DMEM). Mouse embryonic stem cells
(mES) were grown on gelatin-coated plates (Sigma) without feeders in DMEM-
high glucose supplemented with 15% (v/v) fetal bovine serum (GIBCO-Invitro-
gen), LIF, glutamine, and essential aminoacids. Dgcr8/ mES cells were
purchased from Novus Biologicals (NBA1-19349) and the parental strain
(v6.5) from Thermo Scientific (MES1402). Dicer/ and f/f Dicer were kindly
provided by Robert Blelloch (UCSF) (Babiarz et al., 2008). Knock-down of
endogenous proteins was performed in HeLa and SH-SY5Y cells after two
rounds of siRNA transfection using Dharmafect 4 solution (Dharmacon).
Briefly, cells were seeded in 6-well plates to 40% confluence and after 24 hr
were transfected using 25 nM of each siRNA pool and 10 ml of the transfection
reagent. The transfection medium was replaced after 24 hr and cells were
grown for another 24 hr. Cells were then retransfected following the same
protocol and collected 24 hr after the second transfection for analyses.
siRNA pools were purchased from Dharmacon, Drosha (L-016996-00),
DGCR8 (L-015713-00), hRRP6 (L-010904-00), hDIS3 (L-015405-01), hRRP41
(L-013760-00), ZCCHC7 (L-014804-01), RBM7 (L-017936-02), and nontarget-
ing siRNAs (control) (D-001810-02). Overexpression analyses were performed
in HEK293T cells by transfecting plasmids using Lipofectamine 2000 and
following standard manufacturer’s protocol. Antibodies for immunoprecipita-
tions and western blot analyses were the following, anti-DGCR8 antibody
from Abcam (ab90579) and from Santa Cruz Biotech (sc-48473), anti-Drosha
antibody from Novus Biologicals (NBP1-03349), anti-fibrillarin (ab4566),
anti-hRRP6 (ab50558), anti-hRRP41 (ab137250) from Abcam. The anti-
hRRP40 antibody (sc-98776) and anti-dyskerin (sc-48794) were purchased
from Santa Cruz Biotech, and the anti-hDIS3 (14689-1-AP) antibody from
Protein Tech. The anti-FLAG antibody was purchased from Sigma-Aldrich
(F3165, mouse and F7425, rabbit), and the T7-antibody from Merck-Millipore
(65922).
Glycerol Gradients
Glycerol gradients (5%–30%) were poured using the Biocomp gradient
station model 153 (BioComp Instruments, Inc., New Brunswick, Canada)
and contained 50mM Tris (pH 0.5), 150 mM NaCl, and 1 mM EDTA.
Nuclear HEK293T extracts or eluted FLAG immunoprecipitates were
loaded in 11ml 5%–30% glycerol gradients and centrifuged for 16 hr at
41,000 rpms in a Sorvall SW41Ti rotor. Following centrifugation, fractions
(500 ml) were collected manually from the top. When just showing heavy
and light fractions from the gradient, the first 11 fractions were pooled
and precipitated with TCA and the same applies for the next 11 fractions.
All fractions were precipitated using standard TCA precipitation, the pellet
was resuspended in loading buffer and analyzed in Tris-Glycine 4%–12%
gels.
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The accession number for the sequencing data from FLAG-hRRP6 CLIP and
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Figure S1, related to Figure 1. Identification of DGR8 interacting partners by mass 
spectrometry. (A) Mass spectrometry analyses was carried out on immunoprecipitated 
T7-DGCR8, FLAG-DGCR8 and FLAG-Drosha (lanes 2, 4 and 5). As a negative control, 
extracts of cells transfected with control plasmids were immunoprecipitated using T7 
(pCG, lane 1) and FLAG antibody coated beads (FLAG control plasmid, lane 3). (B) List 
of common proteins exclusively co-purified with T7-DGCR8 and FLAG-DGCR8. The list 
of DGCR8-exclusive interacting partners comprises 49 proteins and includes the six 
subunits of the eukaryotic exosome that are highlighted by a red box.
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Figure S2, related to Figure 2. Differential sedimentation pattern of 
native complexes associated with DGCR8 and Drosha. (A) Western-blot 
analyses of immunoprecipitated FLAG-Drosha native complexes in 5-30% 
glycerol gradient fractions (upper panel) and the co-associated DGCR8 
protein (lower panel). (B) Uncropped versions of western-blots shown in 
Figure 2A.
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Figure S3, related to Figure 3. Drosha interacts with the C-terminal region of DGCR8. 
V5-tagged wild-type DGCR8 (V5-D8, lane 2), an empty plasmid control (V5, lane 1), and the 
indicated DGCR8 truncations (numbers represent amino acid positions, lanes 3-9) were trans-
fected in HEK293Ts and subjected to V5 affinity purification, followed by Western blot with 
anti-Drosha antibody (top panel). Inputs are shown in the bottom panel. The middle panel is an 
immunoprecipitation control for Figure 3B. Cells transfected with the same plasmids as in S2A 
were subjected to IgG immunoprecipitation to control for V5-overexpressed proteins unspecific 
binding to antibodies and beads. 
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Figure S4, related to Figure 4. DGCR8 promotes hRRP6 binding to mature snoRNAs. (A) Northern 
blot analyses of the associated mature snoRNAs (mU16 and mU92) to endogenous DGCR8 (lane 3) and 
hRRP6 (lane 4). IgG immunoprecipitation (lane 2) and 7SK hybridization served as negative controls. 
Bottom panel, Western blot analyses of immunoprecipitated DGCR8 and hRRP6. (B) Commassie blue 
staining of FLAG-tagged proteins purified under high stringency conditions. These and similar purifica-
tions were used on Figure 4C, S4C and S4D. (C) (D) EMSA analysis of pri-miR-30c-1 (C) and U1 
snRNA, as a negative control (D), in the presence of increasing amounts of purified FLAG-DGCR8, 
FLAG-hRRP6 and FLAG-hRRP6 CAT (D313N, catalytically dead mutant). The molar excess of protein 
versus radiolabelled RNA is indicated at the top of the panel (1x corresponds to 2.5 nM of protein and 2.5 
nM of radiolabelled RNA), asterisk (*) denotes the well. (E) Analysis of human overexpressed FLAG-
hRRP6 association to snoRNAs in mouse embryonic stem cells in the presence (Dgcr8 +/+) or absence 
 (Dgcr8 -/-) of DGCR8 by qRT-PCR. (F) Western blot analyses of immunoprecipitated FLAG-hRRP6 that
 was used in the experiment shown in S4E.   
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Figure S5, related to Figure 5. SiRNA mediated depletion of DGCR8 and the 
exosome. (A)Northern blot analyses of U16 snoRNA levels upon depletion of DGCR8, 
hRRP6, hRRP6/hDIS3 and hRRP41in triplicates in HeLa cells. Quantification values 
are shown at the top and expressed as the relative intensity normalized to 7SK signal, 
as a loading control (ImageQuant TL). (B) Quantification of mature U16 levels in SH-
SY5Y cells upon transient depletion of DGCR8, hRRP6 and a combination of both. (C) 
Mature U16 and U92 (left panel) and host pre-mRNA (right panel) levels were 
quantified in mouse embryonic stem (ES) cells in the presence (Dgcr8 +/+) or absence 
(Dgcr8 -/-) of DGCR8. (D) RNA levels of DGCR8, hRRP6, hRRP41, hDIS3, ZHCCH7 
and RBM7 following siRNA mediated depletion in HeLa cells were analyzed by qRT-
PCR. These samples were used on Figures 5B, 5C, S5A and 7D. (E) RNA levels of 
DGCR8 and hRRP6 followed siRNA-mediated depletion were measured in SH-SY5Y 
cells by qRT-PCR, these samples were used on Figure S5B and S7A. Values 
represented in (B) (C) (D) and (E) are the average of at least three biological replicates 
+/- s.e.m. Asterisks denote significant p-value (≤ 0.05) by Student’s t test. 
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Figure S6, related to Figure 6. DGCR8 and RRP6 control mature snoRNA levels. 
(A) Commonly upregulated snoRNAs in RNA-seq data from HeLa cells depleted of DGCR8 
(siDGCR8) and hRRP6 (sihRRP6). Average counts are calculated from three biological replicates and 
fold change is calculated from each condition vs mock depleted cells (siControl). (B) Northern blot 
analyses of eight different human snoRNAs upon transient depletion of DGCR8 in HeLa cells. Quanti-
fication values are shown at the bottom of each gel (ImageQuant TL). 7SK hybridization serves as a 
loading control. (C) Analysis of snoRNA levels in EXOSC10 KO mouse ES cells (Pefanis et al., 2015). 
Y-axis shows the log2FC (Fold Change) of snoRNA levels in KO vs. WT cells, and the x-axis is the 
mean TPM (Tags per million). In red are marked snoRNAs with a log2FC ≥ 1 or ≤ -1. The numbers in 
the legend represent the number of upregulated (up=64, log2FC ≥ 1) or downregulated (down=18, 
log2FC ≤ -1) snoRNAs.
snoRNA 
Average counts Fold change (vs. siControl) 
siControl sihRRP6 siDGCR8 sihRRP6 siDGCR8 
SNORD116-19 84.67 202.67 179.67 2.39 2.12 
SNORD116-14 102.33 159.67 171.33 1.56 1.67 
SNORD111 20.67 32.00 30.67 1.55 1.48 
SCARNA4 48.67 63.67 62.00 1.31 1.27 
SNORA19 33.33 52.00 42.33 1.56 1.27 
SNORA11 56.67 71.33 71.67 1.26 1.26 
snoU13 23.00 27.67 28.67 1.20 1.25 
SNORA53 472.00 588.33 567.33 1.25 1.20 
SNORA42 41.33 66.00 49.67 1.60 1.20 
SNORD116-13 210.00 230.00 252.00 1.10 1.20 
SCARNA7 3480.33 3980.33 4128.67 1.14 1.19 
SNORD111B 37.33 44.33 43.33 1.19 1.16 
SNORA46 58.67 71.33 67.67 1.22 1.15 
SNORA80 42.00 52.67 48.33 1.25 1.15 
snoU13 23.00 28.33 26.33 1.23 1.14 
SNORD6 68.33 98.67 78.00 1.44 1.14 
SCARNA5 1412.33 1744.33 1606.33 1.24 1.14 
SNORD53 42.67 65.67 47.33 1.54 1.11 
SNORD116-7 63.00 79.67 69.33 1.26 1.10 
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Figure S7
Figure S7, related to Figure 7. DGCR8/exosome complex, but not Drosha, 
control hTR levels. (A) SH-SY5Y cells were depleted of DGCR8 and hRRP6 and 
hTR levels were quantified by qRT-PCR (for depletion levels see Figure S5E). (B) The 
RNA levels of Drosha were quantified by qRT-PCR following siRNA depletion of 
Drosha in HeLa cells. These samples were used in Figure 7D. Values represented in 
(B) and (C) are the average of at least three biological replicates +/- s.e.m. Asterisks 
denote significant p-value (≤ 0.05) by Student’s t test. (C) Dot blot analyses of 
genomic DNA from Dgcr8 -/- and Dicer -/- mouse ES cells and parental cell lines 
(Dgcr8 +/+ and Dicer +/+) using a telomere repeat probe (TTAGGGx3) and a minor 
satellite probe as a loading control. 
  
SUPPLEMENTAL TABLES 
 
Table S1. Identification of Factors Interacting with DGCR8 and Drosha by Mass 
Spectrometry Analyses, Related to Figure 1 (Excel file). 
Final list of all proteins identified as interactors of DGCR8 and Drosha. 
Table S2. Oligonucleotides Used in this Study, Related to Experimental Procedures. 
5'-3' Sequence Description 
GAATTGTCAGGAATTTGCAGTTAACTTGGAGCACCAC hRRP6 mutagenesis residue D313N  
GTGGTGCTCCAAGTTAACTGCAAATTCCTGACAATTC 
TGCCTGCTGTCAGTAAGCTG human mature U16 qRT-PCR 
TGCTCAGTAAGAATTTTCGTCAA 
TGCCTGCTGTCAGTAAGCTG human precursor (3'end side) U16 qRT-PCR 
GGCCTCCACGACACATCTAT 
GTCACCATGCCTCCCTAGAA human mature U92 qRT-PCR 
ATCTGTCTGCCCCGTATCTG 
CGGGACGAATTGAGTGAAAT human precursor U92 qRT-PCR 
AAAGAGGCAGGGCTAAAAGG 
AGCTGAGGCGCTGCTTCT human pri-miR-24 qRT-PCR 
CCTCGGGCACTTACAGACA 
CATCCCCGATAGAGGAGGAC human 7SK qRT-PCR 
GCGCAGCTACTCGTATACCC 
TGGCTCGAATTCCAAGAGTT mouse host pre-mRNA U16 qRT-PCR 
CAGTTGGTCAGTTGCCAAGA 
CTCTGTTCACAGCGACAGTTG mouse mature U16 qRT-PCR 
TTCGTCAACCTTCTGAACCA 
TGGTTCAGAAGGTTGACGAA mouse precursor U16 (3'end side) qRT-PCR 
CCCACGACACATCTGTTTTC 
CCAAGTGCTGGGATTAAAGG mouse host pre-mRNA U92 qRT-PCR 
TGTCCTCAGCACCCTAACAA 
CACTGGACCTCCCCAGAGTA mouse mature U92 qRT-PCR 
AATTGTCTGCCCCGTATCTG 
CAGGGCGAATTGAGTGAAAT mouse precursor U92 (3'end side) qRT-PCR 
GCACAGGGCTGAAAGAAAAA 
GACATCTGTCACCCCATTGA mouse 7SK qRT-PCR 
GCCTCATTTGGATGTGTCTG 
ACAAGGAATTCGCGCCACCCAGTACCCGGGAGCC hRRP6 cDNA amplification for cloning, 
containing restriction sites 
ACAGTGGCGGCCGCTCCTATCTCTGTGGCCAGTTGTACCTG 
GGCGGTCGGTCGGTGAGGCTTTC human DGCR8 mRNA qRT-PCR 
GGGGCTCTCATCTGTCTCCAT 
ACCCAAGGACCACAGAACAG human RRP6 mRNA qRT-PCR 
TCCAGCAAAAGCCTTGAAGT 
  
GCTCTGCTTCGAAAACATCC human DIS3 mRNA qRT-PCR 
GCCTGATCCAAAGACTCAGC 
CCCTAACTGAGAAGGGCGTA hTR RNA qRT-PCR 
TGCTCTAGAATGAACGGTGGA 
TCTTAGGACTCCGCTGCC mouse TERC (mTR) qRT-PCR 
CCCACAGCTCAGGTAAGACA 
CGGTTTGTTTGGGTTTGGGTTTGGGTTTGGGTTTGGGTT mouse telomeric repeat quantification (Callicott 
2006) 
GGCTTGCCTTACCCTTACCCTTACCCTTACCCTTACCCT 
GAGGGCCAAGTTGGACAGTG mouse genomic c-myc for normalization 
(Callicott 2006) 
TTGCGGTTGTTGCTGATCTG 
CATGCCCGAACCTACACTG human Drosha mRNA qRT-PCR 
GGTCCTTTCCCACAGCCTAT 
CAACGGATTTGGTCGTATTG human GAPDH mRNA primers 
GGAAGATGGTGATGGGATTT 
TAGTTCAGCGACCTTCAGCA human hRRP41 mRNA qRT-PCR 
GAGGATGGCTGCTTCGAAAG 
TTTCGAGCTTTTCCACCAGG human RBM7 mRNA qRT-PCR 
GTGGGGCATGACTACTTCCT 
GTCATCAGGGAGGAAGAGCA human ZHCCH7 mRNA qRT-PCR 
TCTGACCCATCTGACAGCTG 
TGCTCAGTAAGAATTTTCGTCAA anti-U16 snoRNA oligo for Northern detection 
ATCTGTCTGCCCCGTATCTG anti-U92 snoRNA oligo for Northern detection 
AGGCCATTTTCATTCAGCCC anti-SNORD6 snoRNA oligo for Northern 
detection 
CAGGCTCACAGCTCAGAAAA anti-SNORD31 snoRNA oligo for Northern 
detection 
TTCACGGTAAATCCAAAGGTG anti-SNORD58A snoRNA oligo for Northern 
detection  
CTGTTCTCAGAAGGAAGGCA anti- SNORD83A snoRNA oligo for Northern 
detection 
AATCAGACAGGAGCAATCAGGGTGTTGCAA anti-SNORD118 snoRNA oligo for Northern 
detection 
GGGGACGTTTGTTCATAGGG anti-SNORA11 snoRNA oligo for Northern 
detection 
GTGAAGGCTGCTCTCTCCAA anti-SCARNA4 snoRNA oligo for Northern 
detection 
GATCATGCACCATCACACCC anti-SCARNA5 snoRNA oligo for Northern 
detection 
TGCTCTAGAATGAACGGTGGA anti-hTR oligo for Northern detection 
GCGCAGCTACTCGTATACCC anti-7SK oligo for Northern detection 
TTAGGGTTAGGGTTAGGG anti-Telomere repeat oligo (Prakas Hande et al, 
Human Mol Genet 2001) 
GACTGAAAAACACATTCGTTGGAAACGGGATTTGTAGAAC
AGTGTATATCAATGAGTTACAATGAG 
anti-Minor satellite mouse oligo (Denis et al, 
Genes Dev 2001) 
CTTGCGAAGAATAAAAAGAAACGAGCTACACTGG  site directed mutagenesis dRBD1 DGCR8  
CCAGTGTAGCTCGTTTCTTTTTATTCTTCGCAAG 
GTTGGAAAGCAGTTAAAGAAACAGAAGATCCTTC site directed mutagenesis dRBD2 DGCR8 
GAAGGATCTTCTGTTTCTTTAACTGCTTTCCAAC 
ACAAGGAATTCATGGACTACAAAGACCATGACGG cloning of FLAG-hRRP6 in pEF1alfa-IRES-
RED (containing restriction sites) 
TTGTGTCGACCTATCTCTGTGGCCAGTTGTACCTG 
  
SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
 
Immunoprecipitation and Mass Spectrometry analysis 
HEK293T cells were transfected with T7-tagged DGCR8 and pCG backbone as a negative 
control (for full description see (Macias et al., 2012)). An N-terminus 1x FLAG-DGCR8 (a 
gift from Sonia Guil), a C-terminus FLAG-Drosha (a gift from Narry Kim) and an empty 
FLAG control vector were also used. Cells overexpressing DGCR8 or Drosha proteins were 
collected 48 h after transfection, resuspended in buffer D (20mM Hepes-KOH pH 7.9, 100mM 
KCl, 0.2mM EDTA, 0.5mM DTT, 0.2mM PMSF, 5% glycerol) and sonicated with Bioruptor 
for 5 cycles (30 sec on 30 sec off) containing RNAse A or RNAse inhibitors, centrifuged for 
10 min at maximum speed, and the supernatant was added to beads overnight at 4°C. For 
purification of T7-DGCR8, T7 tag antibody agarose from Novagen was used (69026), for 
FLAG-Drosha and FLAG-DGCR8, anti-FLAG M2 affinity from Sigma (A220) was used. 
After immunoprecipitation, beads were washed for 5 times with buffer D (150 mM KCl). For 
mass spectrometry purposes, beads were washed 5 times with buffer D (200 mM KCl). 
Immunoprecipitated material were loaded in Tris-Glycine gels (Invitrogen) and run for 1-2 cm, 
so each individual sample was sent as a unique gel slice. The mixture of proteins was analyzed 
by nLC-MS-MS at the ‘FingerPrints’ Proteomics Facility (University of Dundee). Proteins that 
co-purified with FLAG or pCG immunoprecipitations were used as a background for DGCR8 
and Drosha purifications. True interactors were defined as those proteins with a mascot score 
ratios >1 LOG2 (IP mascot score/Control mascot score), and small and large subunit ribosomal 
proteins were removed from the final list of interactors (see Table S1). For Gene Ontology 
analysis of the DGCR8-interacting proteins the DAVID Bioinformatic Resources 6.7 was used 
(Huang et al., 2009). For the purification of endogenous DGCR8 and hRRP6, 1 µg of antibody 
was coupled to Protein G Dynabeads (10001D, Invitrogen), in the presence of total cell extracts 
prepared in IP buffer (50mM Tris pH 7.5, 150 mM NaCl, 1mM EDTA and 1% Triton X100). 
  
After overnight binding, beads were washed 5 times, 10 minutes each at room temperature, 
with IP buffer. For RNA co-immunoprecipitations, RNA was extracted from the beads, as well 
as from inputs, using Trizol LS (Invitrogen) and following manufacturer’s instructions. RNA 
samples were treated with RQ1 DNAse (Promega, M610A) for 1 h at 37°C, phenol/chloroform 
extracted and ethanol precipitated. For qRT-PCR experiments, input and immunoprecipitated 
RNA were quantified using SuperScript III Platinum SYBR Green One-Step qRT-PCR Kit 
(Invitrogen, 11736-051). The immunoprecipitated RNA was normalized to the input fraction 
and was expressed relative to the negative control (IgG) (set arbitrarily to 1). Primers used for 
these analyses are listed in Table S2. For the analysis of native DGCR8 and Drosha complexes, 
immunoprecipitates from FLAG-DGCR8 and FLAG-Drosha were washed at low salt 
conditions (150mM KCl-buffer D) and eluted by using 1x and 3x FLAG peptide (F3290 and 
F4799, respectively) during 6 h at 4°C. Beads were then centrifuged at 8000 g for 1 min, and 
the supernatant was used to load gradients. For EMSA analysis, FLAG immunoprecipitates 
were washed at high salt conditions (1M KCl-buffer D) to eliminate associated factors, and 
eluted using FLAG peptide as described above and quantified using Bradford protein assay. 
V5-tagged proteins were immunoprecipitated with V5-antibody coated beads (Sigma-Aldrich, 
A7345), following the same protocol as for endogenous protein immunoprecipitations (IP 
buffer). 
 
Plasmid construction 
FLAG-hRRP6 was amplified from a cDNA clone (Origene) using the primers listed in Table 
S2 and cloned in a pcDNA3-3xFLAG vector. The FLAG-hRRP6 catalytically inactive mutant 
(D313N) was generated by Quickchange site-directed mutagenesis kit from Stratagene by 
mutating the wild-type sequence (FLAG-hRRP6 plasmid) and was based on the mutation 
described previously (Januszyk et al., 2011).  The plasmid overexpressing FLAG-hRRP6 in 
  
mouse ES cells was generated by PCR amplification of the FLAG-hRRP6 ORF and cloning 
into pEF1alfa-IRES-RED. The mutant DGCR8 expression vector (T7-DGCR8 dRBD1&2 
mut) was generated by Quickchange site-directed mutagenesis kit from Stratagene based on 
(Yeom et al., 2006). For all the primers used for cloning see Table S2.  
 
RNA extraction and quantitative RT-PCR  
Total RNA was isolated from cells using Trizol (Invitrogen) and treated with DNAse (RQ1 
DNAse, Promega, M601A) and checked for DNA contamination by PCR. For one step qRT-
PCR, 500 ng of total RNA was used with SuperScript III Platinum SYBR Green One-Step 
qRT-PCR Kit (Invitrogen, 11736-051) on CFX96 real time system. Data was analysed with 
Bio-Rad CFX Manager software. All experiments, unless stated, show the average and standard 
error of the mean of at least three independent biological replicates. Primers for qRT-PCR 
analysis are listed in Table S2. 
 
Northern Blot Analysis and probes 
Total RNA or RNA extracted after immunoprecipitation of the protein of interest was loaded 
in a 6% TBE-UREA gel. After running, gel was transferred to Nylon+ membrane (GE 
Healthcare, RPN119B), and pre-hybridized at 40°C for four hours in Church buffer (1% BSA, 
1mM EDTA, 0.5M phosphate buffer, 7% SDS). Radioactive 5’end-labeled oligonucleotides 
against the RNA of interest were added to the pre-hybridization buffer and incubated O/N at 
40°C. First wash was performed with wash buffer 1 (2xSSC, 0.1%SDS) for 1 hour at 40°C, 
and a second wash with washing buffer 2 (1xSSC, 0.1%SDS) for an additional hour at 40°C. 
Oligonucleotides used for hybridization purposes are listed in Table S2. 
 
 
  
Radioactive RNA labeling and in vitro processing reactions 
Templates for RNA synthesis and radiolabeling were obtained by PCR containing the T7 
promoter as described in (Macias et al 2012). Transcription reactions were performed with T7 
polymerase (Ambion, AM2082) in the presence of 40 μmols of 32P-αUTP. Probes were gel-
purified, phenol-extracted and ethanol precipitated following standard procedures. 
Approximately 50,000 cpms of each probe were incubated with 15 ul of immunoprecipitated 
T7-DGCR8, T7-DGCR8 dRBD1&2 mut, FLAG-Drosha, FLAG-hRRP6, FLAG-hRRP6 
mutant and control immunoprecipitate, which were washed with low stringency conditions 
(150 mM KCl), in the presence of buffer A (0.5mM ATP, 20mM creatine phosphate and 3.2 
mM MgCl2). Reactions were incubated for 30 min at 37°C, followed by standard 
phenol/chloroform extraction and ethanol precipitation.  RNAs were resolved in an 8-10% 
1xTBE poly-acrylamide urea gel. Gels were analyzed using Phosphorimager (FLA-5100 
Phosphorimager Fuji).   
 
EMSA analysis 
Reactions contained 40mM Tris-HCl pH 7.9, 6mM MgCl2, 10mM DTT, 10mM NaCl, 2mM 
spermidine, 0.05% Tween, 20 ug of yeast tRNA, RNase inhibitor, 0.05 pmols of alfa-UTP 
internally labelled RNA and the same molar quantity (1x) or increasing amounts of the purified 
protein (FLAG-tagged DGCR8 and Drosha proteins generated by immunoprecipitation in 
high-washing conditions, 1M KCl, and FLAG-hRRP6 and hRRP6-CAT in 2.5M KCl 
conditions) and incubated for 20 min at room temperature. Samples were separated in a 6% 
polyacrylamide (19:1) gels at 200V and exposed in autoradiography films.  
 
 
 
  
Immunofluorescence 
Cells were grown on coverslips, fixed with 4% paraformaldehyde, washed with PBS and 
permeabilized with 0.2% Triton X-100. Coverslips were then incubated for 1 hour with 
blocking buffer (1% BSA, 0.01% Triton X-100 in PBS). Primary antibodies used to detect 
nucleolin (MA1-20800, Thermo Scientific) and T7 overexpressed proteins (Merck-Millipore, 
65922); and secondary antibodies used were anti-rabbit Alexa Flour® 488 (A11070, Molecular 
Probes) and anti-mouse Alexa Flour® 594 (A21203).  All antibodies were diluted to working 
concentrations in diluted blocking buffer (1:1000) and incubated with coverslips in humidified 
chamber overnight at 4°C. Coverslips were washed 3 times with wash buffer (0.01% Triton X-
100 in PBS). Secondary antibodies were incubated with coverslips in a dark, humidified 
chamber for 2 hours at room temperature. Coverslips were then washed with washing buffer 
and mounted with DAPI containing mountant. Images taken on Ziess Axioplan2 with an 
objective lens mounted to a PIFCO collar. Images were deconvolved and processed using 
Volocity.  
 
Nucleolar purification 
Ten 150mm plates of HeLa cells were collected by trypsinization when ~90% confluent.  
Nucleolar purification was essentially carried out as previously described 
(http://www.lamondlab.com/f7nucleolarprotocol.htm) with one modification; S3 buffer was 
supplemented with 0.1mM MgCl2.  Antibodies employed as nucleoplasmic markers were anti-
Lamin B (ab16048, Abcam) and anti-eIF4A3 (ab115022, Abcam); and as a nucleolar marker 
anti-fibrillarin (ab4566-250, Abcam). 
 
 
 
  
Dot blots for telomere repeat quantification 
Different amount of genomic DNA (1ug, 500 ng and 250 ng) was diluted in a solution 
containing 0.4M NaOH and 10mM EDTA and denature at 100°C for 10 min. After cooling on 
ice, samples were applied to a Hybond N+ membrane using a Manifold vacuum system. 
Membrane was previously rinsed in water. After DNA was applied to the membrane, a wash 
step with 0.4M NaOH was performed. The membrane was finally washed twice with 2xSSC 
and air-dried. For detection of telomere repeats, membrane was pre-hybridized overnight at 
40°C in Church buffer (1% BSA, 1mM EDTA, 0.5M phosphate buffer and 7% w/v SDS). The 
oligonucleotide used for detection of telomere repeats was 5’end labelled with T4 PNK 
(M0201, NEB) following the manufacturer’s instructions. The radiolabelled oligonucleotide 
was then added to the pre-hybridization solution and incubated overnight at 40°C. Membrane 
was after washed at 40°C for 2 times during 30 min with wash buffer 1 (2XSSC, 0.1% SDS) 
and once for 30 min with wash buffer 2 (1xSSC, 0.1%SDS). Dot blots were analyzed using 
Phosphorimager (FLA-5100 Phosphorimager Fuji).   
 
Telomere length analysis 
Average telomere length was measured by real time quantitative PCR from genomic DNA 
extracted from Dgcr8  +/+, Dgcr8 -/-, Dicer +/+ and Dicer -/- cell lines following a previously 
described protocol (Callicott and Womack, 2006). Primers used for this experiment are listed 
in Table S2. 
 
Analysis of DGCR8 HITS-CLIP and hRRP6-iCLIP libraries 
Reads were pre-processed using custom python scripts. First, reads were demultiplexed 
according to their fixed barcode allowing up to 1 mismatch. Next, reads were trimmed to 
remove low quality scores and 3’ adapter sequences. Finally, duplicated reads containing 
  
identical random barcodes were removed and the 5’ random barcodes were trimmed. After 
these steps, all reads longer than 19 nucleotides were further analysed. Reads were mapped to 
the human genome (hg19) using bwa-pssm (Kerpedjiev et al., 2014). All reads that were not 
confidently mapped (posterior probability PP <= 0.99) were then mapped to an exome index 
containing all collapsed exons from human ensembl70 transcripts (Flicek et al., 2014). Finally, 
all reads unmapped to the genome were mapped to an exon-junction index containing all 
annotated unique exon-junctions from human ensembl70 transcripts. Only reads mapped at any 
of the steps with a PP > 0.99 were considered for further analysis.  
Reads from the 2 CLIP biological replicates were pooled and clustered together according to 
their genomic positions. Significant clusters were calculated using Pyicos (Althammer et al., 
2011) and only significant clusters with a false discovery rate (FDR) < 0.01 were considered 
for further analysis. DGCR8 significant clusters were obtained from (Macias et al., 2012) 
(http://regulatorygenomics.upf.edu/Data/DGCR8/). We only downloaded the data of the 
second replicate both for the endogenous and the overexpressed experiments. For each of the 
datasets, the coordinates of the significant clusters were mapped from hg18 to hg19 using 
liftOver tool (Kuhn et al., 2013). To define a set of reproducible DGCR8 CLIP clusters, T7-
DGCR8 and endogenous DGCR8 significant clusters were overlapped according to their 
genomic coordinates using fjoin (Richardson, 2006). DGCR8 reproducible clusters and hRRP6 
significant clusters were overlapped based on their genomic coordinates using fjoin. These 
common clusters were then overlapped with the ensembl70 annotation using fjoin to identify a 
set of target genes bound by both DGCR8 and hRRP6. 
 
Standardized snoRNA profiles 
To make standardized profiles, annotated SNORD, SCARNA and SNORA were with at least 
30% RNA-seq coverage in HEK293 cells were selected from ensembl70 annotation. The RNA-
  
seq used to calculate the RNA-seq coverage of the snoRNAs was a pool of published RNA-
seq datasets from (Baltz et al., 2012; Kishore et al., 2011) (GSM714684; GSM714685; 
GSM940576), which were mapped using the same pipeline described above. 
To make the profiles, each annotated snoRNAs was divided in 20 equally sized bins. We also 
included 50nt at each flank of the annotated snoRNA, which were divided in 5 equally sized 
bins. In each bin we calculated the mean enrichment per nucleotide of iCLIP ?̅?𝑏 for bin b as  
?̅?𝑏 =
1
𝑔
∑
1
𝑙𝑖
∑
𝑒𝑖
106
𝑙𝑖
𝑗=1
𝑔
𝑖=1
 
where 𝑔 is the total number of snoRNAs considered, 𝑙𝑖 is the length of the bin and  𝑒𝑖 is the 
number of iCLIP reads mapped to the bin. 
 
Analysis of hRRP6 and DGCR8 knockdown RNAseq data 
The total RNA from three biological replicates for each knockdown condition was sequenced 
using Illumina HiSeq2500s. The reads were trimmed using fastx-trimmer (fastx version 
0.0.13) with options -f 11 -l 110 -Q 33. Reads were mapped to the human hg19 (GrCh37) 
genome, using tophat version 2.0.10, with the options --library-type fr-firststrand -r -50 --
mate-std-dev 40. Raw reads counts were generated using Ensembl 75 (GrCh37.p13) genes 
annotation and featureCounts (from the subread package, version 1.4.6) with the options -s 2 
–p.  
 
Analysis of EXOSC10 KO mouse embryonic cells data 
Processed RNA-seq data from wild type and Exosc10 KO mouse embryonic cells (mESC) was 
obtained from Pefanis et al., (2015) as BigBed files containing TPM for each condition 
(courtesy from the authors). For each condition, TPM values were overlapped with snoRNA 
  
and scaRNA annotation from Ensembl67 (Flicek et al., 2014) using fjoin (Richardson, 2006). 
For each gene, the average TPM value in each condition was calculated. 
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